Interferon gamma receptor 1-Janus kinase 1-Signal transducer and activator of transcription 3-Interferon regulatory factor 1 signaling pathway (IFNγR1-JAK1-STAT3-IRF1 pathway)

The Interferon gamma receptor 1-Janus kinase 1-Signal transducer and activator of transcription 3-Interferon regulatory factor 1 (IFNγR1-JAK1-STAT3-IRF1) signaling pathway is a critical biochemical axis that translates extracellular immune signals into specific gene expression patterns. Upon the binding of Interferon-gamma to the IFNγR1 subunit, the associated Janus kinase 1 (JAK1) undergoes activation and phosphorylates the Signal transducer and activator of transcription 3 (STAT3) (Source: UniProt P15260, P23458). Phosphorylated STAT3 then translocates to the nucleus to induce the transcription of Interferon regulatory factor 1 (IRF1), which serves as a key regulator of the adaptive immune response and tumor suppression (Source: PubMed PMC4049570, UniProt P10914). While STAT1 is the canonical mediator of IFN-gamma signaling, the STAT3-IRF1 branch is increasingly recognized for its role in modulating inflammatory environments and cell survival in various disease contexts (Source: PubMed PMC6521068). Dysregulation of this pathway is associated with the progression of autoimmune disorders and the development of certain malignancies, making its components attractive therapeutic targets. Current clinical strategies primarily utilize JAK inhibitors to disrupt this signaling cascade, providing relief in conditions such as rheumatoid arthritis and myelofibrosis (Source: FDA Labeling).

Other names

IFN-gamma/JAK1/STAT3/IRF1 axisType II Interferon signaling pathwayIFNGR1-JAK1-STAT3-IRF1 signaling

Inhibition of Janus kinase 1 (JAK1) enzymatic activity prevents the phosphorylation of STAT3, thereby blocking its dimerization, nuclear translocation, and the subsequent transcriptional induction of IRF1-dependent genes.